GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Change In Payables And Accrued Expense

Aroa Biosurgery (ASX:ARX) Change In Payables And Accrued Expense : A$0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Change In Payables And Accrued Expense?

Aroa Biosurgery's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Mar. 2024 .

Aroa Biosurgery's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was A$0.00 Mil. It means Aroa Biosurgery's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .


Aroa Biosurgery Change In Payables And Accrued Expense Historical Data

The historical data trend for Aroa Biosurgery's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Change In Payables And Accrued Expense Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Change In Payables And Accrued Expense
- - - - -

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

Aroa Biosurgery Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aroa Biosurgery Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines